benzylpenicilloyl g has been researched along with cholestanol in 1 studies
| Studies (benzylpenicilloyl g) | Trials (benzylpenicilloyl g) | Recent Studies (post-2010) (benzylpenicilloyl g) | Studies (cholestanol) | Trials (cholestanol) | Recent Studies (post-2010) (cholestanol) |
|---|---|---|---|---|---|
| 45 | 4 | 0 | 597 | 37 | 128 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Weck, AL; Lüscher, IF; Weber, E | 1 |
1 other study(ies) available for benzylpenicilloyl g and cholestanol
| Article | Year |
|---|---|
The introduction of one or two 3 beta-cholestanyl residues into benzylpenicilloyl-eicosa-L-lysines greatly potentiates their tolerogenicity for anti-benzylpenicillol IgE antibody formation.
Topics: Animals; Antibody Formation; Benzeneacetamides; Cholestanes; Cholestanol; Cholesterol; Cyclophosphamide; Female; Immunoglobulin E; Immunoglobulin G; Immunosuppression Therapy; Lymphocyte Depletion; Male; Mice; Mice, Inbred BALB C; Penicillin G; T-Lymphocytes, Regulatory; Teratogens | 1984 |